Quick Takeaways
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for JANUX THERAPEUTICS, INC. Common Stock (JANX).
- Disclosed ownership: 7.5%.
- Date of event: 30 Jun 2025.
JANUS HENDERSON GROUP PLC - 30 Jun 2025 SCHEDULE 13G/A Report for JANUX THERAPEUTICS, INC. Common Stock (JANX)
- Filing Manager
- JANUS HENDERSON GROUP PLC
- Reporting Manager
- JANUS HENDERSON GROUP PLC
- Symbol
- JANX
- Shares outstanding
- 59,471,093 shares
- Disclosed Ownership
- 4,460,332 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 11:26:39 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 14 May 2025
- Next filing
- 07 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"JANUS HENDERSON GROUP PLC disclosed 7.5% ownership in JANUX THERAPEUTICS, INC. Common Stock (JANX) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 14 May 2025.
- Current filing was accepted on 14 Aug 2025, 11:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 7.5% | 4,460,332 | 0 | 4,460,332 | Kristin Mariani | Head of North America Compliance, CCO |